These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 22310817)

  • 21. Intensive adherence counselling for HIV-infected individuals failing second-line antiretroviral therapy in Johannesburg, South Africa.
    Fox MP; Berhanu R; Steegen K; Firnhaber C; Ive P; Spencer D; Mashamaite S; Sheik S; Jonker I; Howell P; Long L; Evans D
    Trop Med Int Health; 2016 Sep; 21(9):1131-7. PubMed ID: 27383454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Engagement in human immunodeficiency virus care: linkage, retention, and antiretroviral therapy adherence.
    Eaton EF; Saag MS; Mugavero M
    Infect Dis Clin North Am; 2014 Sep; 28(3):355-69. PubMed ID: 25151561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study protocol: Strengthening understanding of effective adherence strategies for first-line and second-line antiretroviral therapy (ART) in selected rural and urban communities in South Africa.
    Gumede SB; de Wit JBF; Venter WDF; Lalla-Edward ST
    PLoS One; 2021; 16(12):e0261107. PubMed ID: 34932588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Realist evaluation of the antiretroviral treatment adherence club programme in selected primary healthcare facilities in the metropolitan area of Western Cape Province, South Africa: a study protocol.
    Mukumbang FC; Van Belle S; Marchal B; Van Wyk B
    BMJ Open; 2016 Apr; 6(4):e009977. PubMed ID: 27044575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring 'generative mechanisms' of the antiretroviral adherence club intervention using the realist approach: a scoping review of research-based antiretroviral treatment adherence theories.
    Mukumbang FC; Van Belle S; Marchal B; van Wyk B
    BMC Public Health; 2017 May; 17(1):385. PubMed ID: 28472938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Barriers to antiretroviral therapy adherence in developed countries: a qualitative synthesis to develop a conceptual framework for a new patient-reported outcome measure.
    Engler K; Lènàrt A; Lessard D; Toupin I; Lebouché B
    AIDS Care; 2018; 30(sup1):17-28. PubMed ID: 29719990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identifying barriers to ART initiation and adherence: An exploratory qualitative study on PMTCT in Zambia.
    Kanguya T; Koyuncu A; Sharma A; Kusanathan T; Mubanga M; Chi BH; Vinikoor MJ; Mubiana-Mbewe M
    PLoS One; 2022; 17(1):e0262392. PubMed ID: 35025923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strategies for optimizing adherence to highly active antiretroviral therapy: lessons from research and clinical practice.
    Stone VE
    Clin Infect Dis; 2001 Sep; 33(6):865-72. PubMed ID: 11512092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A mega-aggregation framework synthesis of the barriers and facilitators to linkage, adherence to ART and retention in care among people living with HIV.
    Hendricks L; Eshun-Wilson I; Rohwer A
    Syst Rev; 2021 Feb; 10(1):54. PubMed ID: 33568216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adherence and plasma HIV RNA response to antiretroviral therapy among HIV-seropositive injection drug users in a Canadian setting.
    Nolan S; Milloy MJ; Zhang R; Kerr T; Hogg RS; Montaner JS; Wood E
    AIDS Care; 2011 Aug; 23(8):980-7. PubMed ID: 21480010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. "That is why I stopped the ART": patients' & providers' perspectives on barriers to and enablers of HIV treatment adherence in a South African workplace programme.
    Dahab M; Charalambous S; Hamilton R; Fielding K; Kielmann K; Churchyard GJ; Grant AD
    BMC Public Health; 2008 Feb; 8():63. PubMed ID: 18282286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Female gender predicts lower access and adherence to antiretroviral therapy in a setting of free healthcare.
    Tapp C; Milloy MJ; Kerr T; Zhang R; Guillemi S; Hogg RS; Montaner J; Wood E
    BMC Infect Dis; 2011 Apr; 11():86. PubMed ID: 21466704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adherence to antiretroviral therapy among HIV-positive children: examination of the role of caregiver health beliefs.
    Steele RG; Anderson B; Rindel B; Dreyer ML; Perrin K; Christensen R; Tyc V; Flynn PM
    AIDS Care; 2001 Oct; 13(5):617-29. PubMed ID: 11571008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors influencing adherence to antiretroviral therapy from the experience of people living with HIV and their healthcare providers in Sierra Leone: a qualitative study.
    Lahai M; Theobald S; Wurie HR; Lakoh S; Erah PO; Samai M; Raven J
    BMC Health Serv Res; 2022 Nov; 22(1):1327. PubMed ID: 36348488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The importance of treatment adherence in HIV.
    Schaecher KL
    Am J Manag Care; 2013 Sep; 19(12 Suppl):s231-7. PubMed ID: 24495293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A qualitative study of community home-based care and antiretroviral adherence in Swaziland.
    Root R; Whiteside A
    J Int AIDS Soc; 2013 Oct; 16():17978. PubMed ID: 24107652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Counselling on Adherence to Antiretroviral Treatment Among People with HIV in Estonia: A Randomized Controlled Trial.
    Uusküla A; Laisaar KT; Raag M; Lemsalu L; Lõhmus L; Rüütel K; Amico KR;
    AIDS Behav; 2018 Jan; 22(1):224-233. PubMed ID: 28717981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A review of barriers and facilitators of HIV treatment among injection drug users.
    Wood E; Kerr T; Tyndall MW; Montaner JS
    AIDS; 2008 Jul; 22(11):1247-56. PubMed ID: 18580603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mapping patient-identified barriers and facilitators to retention in HIV care and antiretroviral therapy adherence to Andersen's Behavioral Model.
    Holtzman CW; Shea JA; Glanz K; Jacobs LM; Gross R; Hines J; Mounzer K; Samuel R; Metlay JP; Yehia BR
    AIDS Care; 2015; 27(7):817-28. PubMed ID: 25671515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiretroviral therapy adherence: testing a social context model among Black men who use illicit drugs.
    Phillips JC
    J Assoc Nurses AIDS Care; 2011; 22(2):100-27. PubMed ID: 21123085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.